PlainRecalls
FDA Drug Low Class III Terminated

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93

Reported: March 27, 2019 Initiated: March 11, 2019 #D-1006-2019

Product Description

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93

Reason for Recall

Subpotent Drug.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
7,081 bottles
Distribution
Nationwide in the United States.
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93. Recalled by Teva Pharmaceuticals USA. Units affected: 7,081 bottles.
Why was this product recalled?
Subpotent Drug.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 27, 2019. Severity: Low. Recall number: D-1006-2019.